HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study (NCT06248008) evaluating denifanstat ...

Denifanstat showed tolerability and a favourable safety profile and most TEAEs were mild or moderate.

NEW YORK, NY, UNITED STATES, June 21, 2023/EINPresswire.com/ -- AC Skin Science, a new anti-aging skin care company, is excited to announce the launch of its "Love ...

Acne vulgaris affects a large proportion of adolescents and young adults and can lead to long-term scarring and psychological distress. Its pathogenesis involves excessive sebum production, bacterial ...